Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels

Ishwarlal Jialal(University of California, Davis), Sridevi Devaraj(Baylor College of Medicine), David S. Balis(Albert Einstein College of Medicine), Scott M. Grundy(Northern Health and Social Care Trust), Beverley Adams‐Huet(Southwestern Medical Center), Daniel T. Stein(Albert Einstein College of Medicine)
Circulation
April 17, 2001
10.1161/01.cir.103.15.1933
Cited by 732

Related Papers

Diagnosis and Management of the Metabolic Syndrome
|Circulation|2005|11.8k
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
|Circulation|2004|6.9k
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
|Circulation|2019|6.2k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k